SL
DGX icon

Sentry LLC’s Quest Diagnostics DGX Stock Holding History

Sentry LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Hold
1,600
– – 0.09% 94
2026
Q1 		$314K Hold
1,600
– – 0.1% 92
2025
Q4 		$278K Hold
1,600
– – 0.08% 105
2025
Q3 		$305K Hold
1,600
– – 0.08% 99
2025
Q2 		$287K Hold
1,600
– – 0.06% 100
2025
Q1 		$271K Hold
1,600
– – 0.05% 102
2024
Q4 		$241K Hold
1,600
– – 0.05% 106
2024
Q3 		$248K Hold
1,600
– – 0.05% 116
2024
Q2 		$219K Hold
1,600
– – 0.04% 117
2024
Q1 		$213K Hold
1,600
– – 0.04% 117
2023
Q4 		$221K Sell
1,600
-105
-6% -$13.8K 0.05% 110
2023
Q3 		$208K Buy
1,705
+105
+7% +$14K 0.04% 112
2023
Q2 		$225K Hold
1,600
– – 0.05% 111
2023
Q1 		$226K Buy
+1,600
New +$229K 0.05% 104

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Sentry LLC's DGX Position: Q2 2026 in Review

Sentry LLC held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,600 shares worth $339K. The position accounts for 0.09% of the portfolio, ranked #94.

Sentry LLC first reported a position in DGX in Q1 2023 and has held it in 14 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Sentry LLC held 1,600 shares of Quest Diagnostics worth $339K as of Q2 2026.
  • Sentry LLC left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.09% of Sentry LLC's portfolio in Q2 2026, its #94 holding.
  • Sentry LLC first reported a position in Quest Diagnostics in Q1 2023 and has held it in 14 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Sentry LLC's 13F filing for Q2 2026, filed 14 Aug 2026.